These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20657427)

  • 1. Pharmaceutical composition of valsartan: beta-cyclodextrin: physico-chemical characterization and anti-hypertensive evaluation.
    Jensen CE; dos Santos RA; Denadai AM; Santos CF; Braga AN; Sinisterra RD
    Molecules; 2010 Jun; 15(6):4067-84. PubMed ID: 20657427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MOF Capacitates Cyclodextrin to Mega-Load Mode for High-Efficient Delivery of Valsartan.
    Zhang W; Guo T; Wang C; He Y; Zhang X; Li G; Chen Y; Li J; Lin Y; Xu X; Wu L; Zhang S; Zhang J
    Pharm Res; 2019 Jun; 36(8):117. PubMed ID: 31161271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical composition of hydrochlorothiazide:β-cyclo-dextrin: preparation by three different methods, physico-chemical characterization and in vivo diuretic activity evaluation.
    Pires MA; Souza Dos Santos RA; Sinisterra RD
    Molecules; 2011 May; 16(6):4482-99. PubMed ID: 21623317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.
    Xu WJ; Liu Y; Shi LL; Cui JH; Cao QR
    Pak J Pharm Sci; 2014 Nov; 27(6):1799-804. PubMed ID: 25362604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles.
    de Azevedo Mde B; Tasic L; Fattori J; Rodrigues FH; Cantos FC; Ribeiro LP; de Paula V; Ianzer D; Santos RA
    Int J Nanomedicine; 2011; 6():1005-16. PubMed ID: 21720512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E; Müller DG; Wessels PL; Venter JP
    Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer.
    Li DX; Yan YD; Oh DH; Yang KY; Seo YG; Kim JO; Kim YI; Yong CS; Choi HG
    Drug Deliv; 2010 Jul; 17(5):322-9. PubMed ID: 20367177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin, an efficient tool for trans-anethole encapsulation: chromatographic, spectroscopic, thermal and structural studies.
    Kfoury M; Auezova L; Greige-Gerges H; Ruellan S; Fourmentin S
    Food Chem; 2014 Dec; 164():454-61. PubMed ID: 24996357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets.
    Shrivastava AR; Ursekar B; Kapadia CJ
    Curr Drug Deliv; 2009 Jan; 6(1):28-37. PubMed ID: 19418953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes.
    Sri KV; Kondaiah A; Ratna JV; Annapurna A
    Drug Dev Ind Pharm; 2007 Mar; 33(3):245-53. PubMed ID: 17454057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly water-soluble valsartan.
    Ha NS; Tran TT; Tran PH; Park JB; Lee BJ
    Chem Pharm Bull (Tokyo); 2011; 59(7):844-50. PubMed ID: 21720034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion.
    Park YJ; Lee HK; Im YB; Lee W; Han HK
    Arch Pharm Res; 2010 Aug; 33(8):1235-40. PubMed ID: 20803127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
    Fernandes CM; Teresa Vieira M; Veiga FJ
    Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion complexation of nimesulide with beta-cyclodextrins.
    Vavia PR; Adhage NA
    Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.